New Mayo Clinic MRI technology enables noninvasive liver diagnosesMay 23, 2007Two recent Mayo Clinic studies have found that magnetic resonance elastography (MRE), a new imaging technique invented at Mayo Clinic, is an accurate tool for non-invasive diagnosis of liver diseases. The findings will be presented this week at the International Society for Magnetic Resonance in Medicine Annual Meeting in Berlin, Germany, and Digestive Disease Week 2007 in Washington, D.C. The liver responds to many diseases that damage its cells by developing scar tissue or fibrosis. MRE uses a modified form of magnetic resonance imaging (MRI) to accurately measure the hardness or elasticity of the liver. By applying vibrations to the liver, MRE obtains pictures of the mechanical waves passing through the organ. The wave pictures are then processed to generate a quantitative image of tissue stiffness. "Healthy liver tissue is very soft, while a liver with fibrosis is firmer, and a liver with cirrhosis is almost rock-hard," says Richard Ehman, M.D., lead researcher on the MRE project. "If detected early, fibrosis of the liver can be treated, but once the disease has progressed to cirrhosis, the condition is irreversible." Dr. Ehman and his imaging research team collaborated with Mayo Clinic gastroenterologists to study whether MRE could provide reliable and accurate diagnoses in patients with varying degrees of liver disease. One study involved MRE examinations of 57 individuals with chronic liver disease and 20 healthy volunteers. The researchers confirmed that MRE accurately detects fibrosis with high sensitivity and specificity. Researchers also found that steatosis, which is deposits of fatty acids and triglycerides in liver cells and a common condition in patients with liver disease, did not interfere with detection of fibrosis with MRE. "Based on this research, we are now using MRE examinations in select patients to determine liver stiffness and assess the need for liver biopsies," says Jayant Talwalkar, M.D., a Mayo Clinic gastroenterologist and an investigator on the MRE studies. "More than 170 million people in the world are known to have hepatitis C, and nearly one-fourth of those will develop severe liver fibrosis. MRE can help us noninvasively identify fibrosis in this large patient population." A second study looked at whether MRE can accurately measure portal hypertension, or high blood pressure in the portal vein that carries blood from the digestive track to the liver, usually as a result of cirrhosis of the liver. This study involved 35 individuals with varying degrees of chronic liver disease and 12 healthy volunteers. Researchers studied MRE examinations of liver and spleen stiffness and found that a highly significant correlation exists between liver and spleen stiffness in patients with portal hypertension. However, the validity of spleen stiffness as a noninvasive measure of portal venous pressure requires further study. According to Dr. Ehman, many diseases cause the properties of tissue to change and will be likely candidates for diagnosis using MRE in the future. His research team is exploring the use of MRE in detecting breast cancer and Alzheimer's disease. Mayo Clinic |
|||||||||||||||||||||
| Related Liver Disease Current Events and Liver Disease News Articles Largest-ever database for liver proteins may lead to treatments for hepatitis Scientists at a group of 11 research centers in China are reporting for the first time assembly of the largest-ever collection of data about the proteins produced by genes in a single human organ. Alcohol Tolerance Switch Found in Fruit Flies Researchers at North Carolina State University have found a genetic "switch" in fruit flies that plays an important role in making flies more tolerant to alcohol. Scientists develop novel method to generate functional hepatocytes for drug testing Scientists have for the first time produced liver cells from adult skin cells using the induced pluripotent stem cell (iPSC) technology. UCSD researchers pave the way for effective liver treatments A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease. Governor recognizes stem cell research at Einstein Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Liver cells grown from patients' skin cells Scientists at The Medical College of Wisconsin in Milwaukee have successfully produced liver cells from patients' skin cells opening the possibility of treating a wide range of diseases that affect liver function. Metabolic syndrome linked to liver disease in obese teenaged boys Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease. Penn State College of Medicine research isolates liver cancer stem cells prior to tumor formation Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer. Genetic hint for ridding the body of hepatitis C More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer. HBV genotype B/B3 and C/C1 are the major genotypes in Indonesia? Previous studies revealed that HBV genotypes as well as mutations in the core promoter, precore or HBx gene have been shown to have an association with the clinical outcome of liver disease, however, this is still controversial. More Liver Disease Current Events and Liver Disease News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||